Anlon Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01025
  • NSEID: AHCL
  • BSEID: 544497
INR
14.61
0.04 (0.27%)
BSENSE

Aug 05, 09:59 AM

BSE+NSE Vol: 2.99 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.99 lacs (-61.32%) Volume

Shareholding (Jun 2026)

FII

1.67%

Held by 6 FIIs

DII

1.23%

Held by 3 DIIs

Promoter

52.68%

Why is Anlon Healthcare Ltd falling/rising?

05-Aug-2026

As of 04-Aug, Anlon Healthcare Ltd's stock price is declining at 14.57, down 0.82%. The stock has underperformed its sector and experienced a significant drop in investor participation, indicating short-term weakness.

As of 04-Aug, Anlon Healthcare Ltd's stock price is falling, currently at 14.57, which reflects a change of -0.12 or -0.82%. The stock has underperformed its sector by 0.7% today and has experienced a trend reversal, having fallen after two consecutive days of gains. Over the past week, the stock has decreased by 6.48%, while the benchmark Sensex has increased by 2.17%. Additionally, the stock's performance over the past month shows a decline of 8.13%, contrasting with a slight gain of 0.86% in the Sensex.<BR><BR>Investor participation has also decreased, as evidenced by a significant drop in delivery volume, which fell by 71.53% compared to the 5-day average. Although the stock is trading above the 100-day and 200-day moving averages, it is below the 5-day, 20-day, and 50-day moving averages, indicating a short-term weakness. Overall, these factors contribute to the current decline in Anlon Healthcare Ltd's stock price.

View full answer

Should I buy, sell or hold Anlon Healthcare Ltd?

31-Jul-2026

Are Anlon Healthcare Ltd latest results good or bad?

30-Jul-2026

Anlon Healthcare Ltd's latest results show strong revenue growth of 78.95% year-on-year, reaching ₹87.56 crores, but a concerning 60% decline in net profit to ₹6.66 crores and significantly reduced margins indicate underlying operational challenges. Investors should be cautious due to these profitability concerns despite the revenue increase.

Anlon Healthcare Ltd's latest results present a mixed picture, leaning towards the negative due to significant profitability concerns despite impressive revenue growth. In Q1 FY27, the company reported a net profit of ₹6.66 crores, which is a substantial decline of 60% year-on-year and a 36.57% drop compared to the previous quarter. This decline in profitability is alarming, especially given the backdrop of a strong revenue increase of 78.95% year-on-year, reaching ₹87.56 crores.<BR><BR>While the revenue growth indicates successful market penetration or new product launches, it came at the cost of severely compressed margins. The operating margin fell dramatically from 30.05% in the previous quarter to 17.80%, and the PAT margin also decreased significantly to 9.46%. This suggests that the company may be facing increased costs or adopting aggressive pricing strategies to gain market share, which raises questions about the sustainability of this growth.<BR><BR>Overall, while Anlon Healthcare has demonstrated strong revenue growth, the substantial decline in profitability and margins indicates underlying operational challenges that need to be addressed. Investors should approach the company's performance with caution, given the current financial dynamics.

View full answer

When is the next results date for Anlon Healthcare Ltd?

28-Jul-2026

The next results date for Anlon Healthcare Ltd is 30 July 2026.

The next results date for Anlon Healthcare Ltd is scheduled for 30 July 2026.

View full answer

What does Anlon Healthcare do?

11-Jun-2026

Anlon Healthcare Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of 51 Cr and a net profit of 10 Cr for the quarter ending March 2026. Key metrics include a P/E ratio of 28.00 and a market cap of INR 795 Cr.

Overview: <BR>Anlon Healthcare Ltd operates in the Pharmaceuticals & Biotechnology industry and is classified as a Micro Cap company.<BR><BR>History: <BR>The incorporation year is not specified, and there are no status changes reported. The latest quarter for which sales and profit are reported is March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 51 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 10 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 795 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 28.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.07 <BR>Return on Equity: 12.98% <BR>Price-to-Book: 3.79 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

View full answer

How big is Anlon Healthcare?

11-Jun-2026

As of 10th June, Anlon Healthcare Ltd has a market capitalization of 795.00 Cr, with recent net sales of 135.40 Cr and a net profit of 32.30 Cr.

As of 10th June, Anlon Healthcare Ltd has a market capitalization of 795.00 Cr, classified as a Micro Cap.<BR><BR>In the latest four quarters, Anlon Healthcare reported Net Sales of 135.40 Cr and a Net Profit of 32.30 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 80.42 Cr and Total Assets of 181.30 Cr.

View full answer

Who are the peers of the Anlon Healthcare?

11-Jun-2026

Anlon Healthcare's peers include Themis Medicare, Bharat Parenter., Wanbury, Kopran, Sigachi Industries, Anuh Pharma, Shree Ganesh Rem, Kilitch Drugs, Zim Laboratories, and Remus Pharma. Management risk varies from excellent at Sigachi Industries to below average at Kilitch Drugs, with growth and capital structure ratings also differing among peers.

Peers: Themis Medicare, Bharat Parenter., Wanbury, Kopran, Sigachi Indust., Anuh Pharma, Shree Ganesh Rem, Kilitch Drugs, Zim Laboratories, Remus Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sigachi Indust., while Average management risk is found at Themis Medicare, Bharat Parenter., Wanbury, Kopran, Anlon Healthcare, Anuh Pharma, Shree Ganesh Rem, Zim Laboratories, and Remus Pharma. Below Average management risk is noted at Kilitch Drugs. Growth is Excellent at Anlon Healthcare and Kilitch Drugs, Good at Wanbury and Remus Pharma, and Below Average at Themis Medicare, Bharat Parenter., Kopran, Sigachi Indust., Anuh Pharma, Shree Ganesh Rem, and Zim Laboratories. Capital Structure is Excellent at Sigachi Indust. and Anuh Pharma, Good at Anlon Healthcare and Kilitch Drugs, and Average at Bharat Parenter. and Zim Laboratories, while Below Average is found at Wanbury and Themis Medicare.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Bharat Parenter. at 6.09%, while the lowest is Sigachi Indust. at -62.44%. Anlon Healthcare's 1-year return is not available for comparison. Additionally, peers with negative six-month returns include Sigachi Indust. and Anuh Pharma.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

  • PAT(Q) At Rs 4.80 cr has Fallen at -31.0% (vs previous 4Q average)
  • NET SALES(Q) Lowest at Rs 30.98 cr
2

With ROE of 13.6, it has a Very Expensive valuation with a 3.6 Price to Book Value

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 777 Cr (Micro Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

37

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.07

stock-summary
Return on Equity

13.56%

stock-summary
Price to Book

3.62

Revenue and Profits:
Net Sales:
88 Cr
(Quarterly Results - Jun 2026)
Net Profit:
7 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.36%
0%
11.36%
6 Months
18.01%
0%
18.01%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Anlon Healthcare Ltd Falls 2.60%: 4 Key Factors Driving the Weekly Decline

Key Events This Week

27 Jul: Stock surges 4.93% amid bullish technical momentum

28 Jul: Technical momentum confirmed bullish despite slight price dip

30 Jul: Quarterly results reveal profit decline despite revenue growth; stock plunges 8.50%

31 Jul: Technical momentum shifts to mildly bullish amid market pressure; stock closes marginally higher

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Anlon Healthcare Ltd has announced 2:10 stock split, ex-date: 24 Apr 26

stock-summary
BONUS

Anlon Healthcare Ltd has announced 1:1 bonus issue, ex-date: 24 Apr 26

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
9.26
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
30.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.89%
ROCE (avg)
9.07%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
30
Industry P/E
37
Price to Book Value
3.62
EV to EBIT
17.24
EV to EBITDA
16.66
EV to Capital Employed
3.45
EV to Sales
4.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
19.58%
ROE (Latest)
13.56%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 6 FIIs (1.67%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (7.53%)

Individual Investors Holdings

26.19%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -44.10% vs 55.76% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -50.97% vs 90.10% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.98",
          "val2": "55.42",
          "chgp": "-44.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.47",
          "val2": "13.91",
          "chgp": "-46.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.96",
          "val2": "1.18",
          "chgp": "-18.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.80",
          "val2": "9.79",
          "chgp": "-50.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.11%",
          "val2": "25.10%",
          "chgp": "-0.99%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.50",
          "val2": "62.00",
          "chgp": "37.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.98",
          "val2": "14.45",
          "chgp": "38.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.68",
          "val2": "1.91",
          "chgp": "-12.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.86",
          "val2": "6.36",
          "chgp": "102.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.37%",
          "val2": "23.31%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "121.08",
          "val2": "71.36",
          "chgp": "69.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.25",
          "val2": "15.03",
          "chgp": "114.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.19",
          "val2": "2.80",
          "chgp": "13.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "18.01",
          "val2": "3.87",
          "chgp": "365.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.64%",
          "val2": "21.06%",
          "chgp": "5.58%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "176.50",
          "val2": "120.29",
          "chgp": "46.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.14",
          "val2": "32.21",
          "chgp": "43.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.35",
          "val2": "3.72",
          "chgp": "16.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "27.81",
          "val2": "20.52",
          "chgp": "35.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.14%",
          "val2": "26.78%",
          "chgp": "-0.64%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
30.98
55.42
-44.10%
Operating Profit (PBDIT) excl Other Income
7.47
13.91
-46.30%
Interest
0.96
1.18
-18.64%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.80
9.79
-50.97%
Operating Profit Margin (Excl OI)
24.11%
25.10%
-0.99%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -44.10% vs 55.76% in Mar 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is -50.97% vs 90.10% in Mar 2026

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
85.50
62.00
37.90%
Operating Profit (PBDIT) excl Other Income
19.98
14.45
38.27%
Interest
1.68
1.91
-12.04%
Exceptional Items
0.00
0.00
Standalone Net Profit
12.86
6.36
102.20%
Operating Profit Margin (Excl OI)
23.37%
23.31%
0.06%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
121.08
71.36
69.67%
Operating Profit (PBDIT) excl Other Income
32.25
15.03
114.57%
Interest
3.19
2.80
13.93%
Exceptional Items
0.00
0.00
Standalone Net Profit
18.01
3.87
365.37%
Operating Profit Margin (Excl OI)
26.64%
21.06%
5.58%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
176.50
120.29
46.73%
Operating Profit (PBDIT) excl Other Income
46.14
32.21
43.25%
Interest
4.35
3.72
16.94%
Exceptional Items
0.00
0.00
Standalone Net Profit
27.81
20.52
35.53%
Operating Profit Margin (Excl OI)
26.14%
26.78%
-0.64%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Anlon Healthcare Ltd stock-summary
stock-summary
Anlon Healthcare Ltd
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available